HKD 0.47
(-7.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 301.24 Million HKD | 23.7% |
2022 | 243.52 Million HKD | 80.37% |
2021 | 135.01 Million HKD | 89.99% |
2020 | 71.06 Million HKD | -60.37% |
2019 | 179.29 Million HKD | -14.74% |
2018 | 210.29 Million HKD | 93.84% |
2017 | 108.49 Million HKD | 63.33% |
2016 | 66.42 Million HKD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 107.8 Million HKD | 0.0% |
2023 Q4 | 137.54 Million HKD | 0.0% |
2023 Q2 | 163.69 Million HKD | 0.0% |
2023 FY | 301.24 Million HKD | 23.7% |
2022 Q4 | 124 Million HKD | 0.0% |
2022 FY | 243.52 Million HKD | 80.37% |
2022 Q2 | 119.52 Million HKD | 0.0% |
2021 FY | 135.01 Million HKD | 89.99% |
2021 Q2 | 63.85 Million HKD | 0.0% |
2021 Q4 | 71.15 Million HKD | 0.0% |
2020 Q2 | 29.38 Million HKD | 0.0% |
2020 Q4 | 41.92 Million HKD | 0.0% |
2020 FY | 71.06 Million HKD | -60.37% |
2019 Q4 | 70.37 Million HKD | 0.0% |
2019 Q2 | 108.92 Million HKD | 0.0% |
2019 FY | 179.29 Million HKD | -14.74% |
2018 Q4 | 47.78 Million HKD | 0.0% |
2018 FY | 210.29 Million HKD | 93.84% |
2018 Q2 | 52.57 Million HKD | 0.0% |
2018 Q1 | 52.57 Million HKD | 0.0% |
2017 Q1 | 27.12 Million HKD | 0.0% |
2017 Q2 | 27.12 Million HKD | 0.0% |
2017 Q4 | 52.57 Million HKD | 0.0% |
2017 FY | 108.49 Million HKD | 63.33% |
2016 FY | 66.42 Million HKD | 0.0% |
2016 Q4 | 27.12 Million HKD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
China Healthwise Holdings Limited | 60.29 Million HKD | -399.627% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.04 Billion HKD | 71.234% |